December 21, 2007 - Edwards Lifesciences Corp. (Edwards) has completed its acquisition of certain assets of the CardioVations Division of Ethicon, Inc., a product line that is expected to give Edwards surgical partners new avenues to optimize patient outcomes.
The CardioVations product line includes the PORT-ACCESS products for performing minimally invasive cardiac valve procedures. The line is expected to generate sales of more than $20 million in 2008. It is not expected to have an impact on earnings in 2008 and will be accretive thereafter.
For more information: www.edwards.com
October 31, 2023 
